Social pairs equal CBD and CBG with a little THCV. CBG is the one to watch here: a small 2024 human study linked it to lower self-reported anxiety and stress, the kind of edge you want off before friends come over. THCV, at low amounts, tends to temper CB1 activity, which is why it's associated with a clearer-headed feel.
How your endocannabinoid system works
Your endocannabinoid system (ECS) is a signaling network your body uses to help keep things in balance, including mood, stress response, appetite, sleep and memory. It has three parts: endocannabinoids your body makes on its own (like anandamide and 2-AG), the receptors they bind to (CB1, found mostly in the brain and nervous system, and CB2, found mostly in immune tissue), and enzymes that break them down when they're done (FAAH and MAGL). Plant cannabinoids interact with this same system, each in its own way.
EndocannabinoidsAnandamide and 2-AG: messengers your body makes on demand.
ReceptorsCB1 (brain and nerves) and CB2 (immune tissue) receive those messages.
EnzymesFAAH and MAGL clear the messengers once they’ve done their job.
In SocialThe same 10mg per segment as every GURU gummy. It sets the strength; the blend around it sets the character.
With your ECSActivates CB1 receptors (a partial agonist), which is where its intoxicating effect comes from. Also acts on CB2.
What research saysThe most studied cannabinoid. Effects depend strongly on amount: lower amounts are generally better tolerated, while higher amounts raise the chance of anxiety or an uncomfortable experience.
Well studied In SocialHalf of the CBD/CBG base.
With your ECSBarely binds CB1 or CB2 directly. It can change how CB1 responds to THC, slows the enzyme (FAAH) that breaks down your own anandamide, and acts on serotonin 5-HT1A and TRPV1 receptors.
What research saysNon-intoxicating and widely studied. Whether it softens THC's effects depends on the ratio and amount, and studies are mixed.
Well studied In SocialThe Social signature, chosen for early research on stress and anxiety.
With your ECSBinds CB1 and CB2 weakly. Also acts on alpha-2 adrenergic receptors and blocks 5-HT1A serotonin receptors.
What research saysNon-intoxicating. A small 2024 double-blind human study found a 20mg dose reduced self-reported anxiety and stress in healthy adults. Promising, but early.
Early research In SocialRounds out the blend, non-intoxicating.
With your ECSWeak at CB1, some activity at CB2. Mainly acts on TRPA1 and TRPV1 receptors and may slow the reuptake of anandamide.
What research saysNon-intoxicating. Most research so far is in lab and animal studies.
Mostly lab research In SocialA small amount, associated with a clearer-headed feel.
With your ECSAt low amounts it tends to dampen CB1 signaling rather than activate it, and it acts as a partial agonist at CB2. At higher amounts it can activate CB1.
What research saysStudied for appetite and metabolism. Its reputation for a clearer-headed experience is mostly anecdotal; human studies are small.
Early research What we can and can't say: THC's effects are well documented. Research on the other cannabinoids is still early. Many findings come from lab or animal studies or small human trials, often at higher amounts than one segment contains. The biggest driver of how a segment feels is its 10mg of THC. Each supporting blend is our formulation choice for that vibe, and we'll keep refining it with Vibe Study feedback.